Montreux Capital Management (UK) (MCM UK) has been nominated for “Investor of the Year” at the prestigious LaingBuisson Awards. The award, given to the very best investors in the industry is drawn from across the whole Healthcare sector. Those shortlisted have demonstrated to the judges a well-executed investment strategy and significant return on capital employed for their investors.

MCM (UK) is amongst prestigious company having been nominated alongside Octopus Group and Cheyne Capital. The award sets the Montreux Healthcare Fund’s return against other participants in the healthcare space and benchmarks the Fund’s successful performance against other leaders in the market.

The Regard Group, the Montreux Healthcare Fund’s Operating Company, was also nominated in the Supported Living category, adding another award nomination to an already successful season for the Group.

Oliver Harris, CEO of Montreux Capital Management (UK), stated: “We are incredibly pleased to be nominated for Investor of the Year. This award carries a lot of weight in the healthcare space as LaingBuisson are widely regarded as the best analysts in the industry. It is a great accolade and a worthy reward for the MCM UK team. We are also pleased to see that Regard has again been recognised as one of the best Supported Living providers in the UK. Of course, we are hopeful that both MCM UK and Regard are successful. I certainly think we would both be worthy winners”.